Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-02-27 @ 6:45 PM
Study NCT ID:
NCT02688608
Status:
COMPLETED
Last Update Posted:
2022-02-10
First Post:
2016-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Sponsor:
Saad A Khan
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STU 012016-019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |